| Element List | Explanation |
|---|---|
| Introduction | Jamjoom Pharmaceuticals Factory Company (the “Company”) is pleased to announce its Board of Directors’ decision to distribute interim dividends to the shareholders for the First half of 2026, as per the details stated below. |
| Date of the board’s decision | 2026-07-21 Corresponding to 1448-02-07 |
| The Total amount distributed | 154,000,000 |
| Number of Shares Eligible for Dividends | 70,000,000 |
| Dividend per share | SAR 2.20 |
| Percentage of Dividend to the Share Par Value (%) | 22 |
| Eligibility date | 2026-07-30 Corresponding to 1448-02-16 |
| Distribution Date | 2026-08-13 Corresponding to 1448-02-30 |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | NA |
| Additional Information | The Company would like to inform its Shareholders of the necessity of updating their data and ensure that their bank account numbers are linked to their investment portfolios to ensure that their dividends are deposited in their accounts with the banks on the distribution day. |
We would like to draw the attention of non-resident foreign investors to the fact that the distributions are transferred through the resident financial intermediary, and when transferred or credited in his account, are subject to a withholding tax of 5% in accordance with the provisions of Article (68) of the tax system and Article (63) of its implementing regulations.
For any inquiries, please directly contact the Investor Relations Department through:
IR@jamjoompharma.com
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.